Table 6 Adverse events during adjuvant chemotherapy
From: Body weight loss after surgery affects the continuity of adjuvant chemotherapy for pancreatic cancer
BWL < 10% | BWL ≥ 10% | p |
|---|---|---|
N = 21 | N = 18 |  |
(Number: CTCAE Grade 4, 3, 2, 1) | ||
Anemia | ||
 (0, 0, 1, 0) | (0, 0, 2, 0) |  |
Leucopenia | ||
 (0, 1, 2, 0) | (0, 1, 3, 0) |  |
Neutropenia | ||
 (0, 3, 2, 1) | (1, 1, 1, 0) |  |
Thrombopenia | ||
 (0, 0, 1, 0) | (0, 0, 0, 0) |  |
Hepatic toxicity | ||
 (0, 1, 3, 2) | (0, 0, 0, 0) |  |
Cholangitis | ||
 (0, 0, 4, 0) | (0, 1, 1, 0) |  |
Diarrhea | ||
 (0, 1, 1, 2) | (0, 1, 3, 2) |  |
Nausea | ||
 (0, 0, 1, 0) | (0, 0, 3, 1) |  |
Eczema | ||
 (0, 0, 1, 0) | (0, 0, 1, 1) |  |
Heart failure | ||
 (0, 0, 1, 1) | (0, 1, 0, 0) |  |
Interstitial pneumonia | ||
 (0, 0, 0, 1) | (0, 0, 0, 0) |  |
Others | ||
 (0, 0, 0, 1) | (0, 0, 2, 0) |  |
Discontinuation of adjuvant chemotherapy (Y: N) | ||
 2: 19 | 9: 9 | 0.011 |